HT
EVH icon

Headlands Technologies’s Evolent Health EVH Stock Holding History

Headlands Technologies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.9K Sell
17,060
-57,724
-77% -$183K ﹤0.01% 704
2025
Q4 		$299K Buy
+74,784
New +$416K 0.03% 520
2025
Q3 		– Sell
-5,120
Closed -$57.7K – 830
2025
Q2 		$57.7K Buy
+5,120
New +$47K 0.01% 747
2024
Q3 		– Sell
-34,850
Closed -$666K – 1288
2024
Q2 		$666K Buy
34,850
+33,439
+2,370% +$854K 0.07% 227
2024
Q1 		$46.3K Buy
+1,411
New +$45K 0.01% 739

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Headlands Technologies's EVH Position: Q1 2026 in Review

Headlands Technologies reduced its Evolent Health (EVH) stake by 77% in Q1 2026, selling an estimated $183K and leaving 17,060 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

Headlands Technologies first reported a position in EVH in Q1 2024 and has held it in 5 quarters since. The position peaked at $666K in Q2 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Headlands Technologies held 17,060 shares of Evolent Health worth $38.9K as of Q1 2026.
  • Headlands Technologies sold 57,724 Evolent Health shares in Q1 2026, an estimated $183K.
  • Evolent Health made up ﹤0.01% of Headlands Technologies's portfolio in Q1 2026, its #704 holding.
  • Headlands Technologies first reported a position in Evolent Health in Q1 2024 and has held it in 5 quarters since.
  • Headlands Technologies's Evolent Health position peaked at $666K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.